CCRAS developed and commercialized Ayurvedic Drugs

Image
Capital Market
Last Updated : Feb 07 2018 | 11:50 AM IST
The Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous body under the Ministry of AYUSH is actively involved in scientific process of drug development adopting prevalent guidelines such as Good Clinical Practices Guidelines for ASU drugs (GCP-ASU), Ministry of AYUSH and National ethical guidelines for Bio-Medical Research (ICMR), WHO guidelines for traditional medicines etc. as per requirement and as feasible through its peripheral institutes. Council through its drug development program is undertaking development of new formulations/drugs taking leads from Ayurvedic literature through a systematic process of drug development. viz standardization, preclinical safety & clinical study as per requirement.

CCRAS has developed and commercialized the following two drugs:

1.AYUSH 82 An Anti Diabetic Ayurvedic Formulation

2.AYUSH SG An Anti-Rheumatoid Arthritis preparation.

CCRAS has also undertaken the development of the following coded formulations which are at different phases of drug development:-

i.AYUSH Manas for Mental retardation/cognitive deficit

ii.AYUSH QOL 2C for improving Quality of Life of Cancer patients

iii.AYUSH Rasayan A & B in geriatric health

iv.AYUSH C1 Oil for wound healing

v.AYUSH PJ-7 for Dengue fever

vi.AYUSH M-3 for Migraine

vii.AYUSH SL for Filariasis

viii.AYUSH A for Bronchial Asthma

ix.AYUSH D for Type II Diabetes Mellitus

x.Carctol S for Cancer

xi.AYUSH K1 for Chronic Kidney Diseases

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 07 2018 | 11:30 AM IST

Next Story